Cargando…

Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia

BACKGROUND: Carbapenem is frequently used when gram negative bacilli (GNB) bacteremia is detected especially in neutropenic patients. Consequently, appropriate treatment could be delayed in GNB bacteremia cases involving organisms which are not susceptible to carbapenem (carba-NS), resulting in a po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Dong Hoon, Shin, Dong-Yeop, Kang, Chang Kyung, Park, Suhyeon, Park, Jieun, Jun, Kang Il, Kim, Taek Soo, Koh, Youngil, Hong, Jun Shik, Choe, Pyoeng Gyun, Park, Wan Beom, Kim, Nam-Joong, Yoon, Sung-soo, Kim, Inho, Oh, Myoung-don
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282079/ https://www.ncbi.nlm.nih.gov/pubmed/32517658 http://dx.doi.org/10.1186/s12879-020-05131-2

Ejemplares similares

Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
por: Oh, Sang-Min, et al.
Publicado: (2021)

116. Risk Factors and Clinical Outcomes of Carbapenem Non-Susceptible Gram-Negative Bacteremia in Patients with Acute Myelogenous Leukemia
por: Hoon Shin, Dong, et al.
Publicado: (2019)

The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study
por: Kim, Ryul, et al.
Publicado: (2017)

Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
por: Chun, June Young, et al.
Publicado: (2021)

Limited Positive Predictive Value of β-d-Glucan in Hematologic Patients Receiving Antimold Prophylaxis
por: Chang, Euijin, et al.
Publicado: (2020)

A Direct Rapid Phenotypic Antimicrobial Susceptibility Test Enables Early Selection of Optimal Antibiotics to Treat Bacteremia in COVID-19 Patients
por: Park, Do Hyeon, et al.
Publicado: (2021)

The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to Genospecies
por: Park, Kyung-Hwa, et al.
Publicado: (2013)

1855. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
por: Lee, Chan Mi, et al.
Publicado: (2022)

Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality
por: Kim, Seong Eun, et al.
Publicado: (2012)

211. Disease burden of bacteremia with extended-spectrum beta-lactamase-producing or carbapenem-resistant Enterobacteriaceae in Korea
por: Mi Lee, Chan, et al.
Publicado: (2023)

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
por: Park, Hyunkyung, et al.
Publicado: (2020)

Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
por: Park, Songyi, et al.
Publicado: (2021)

Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation
por: Park, Woochan, et al.
Publicado: (2023)

Can a routine follow-up blood culture be justified in Klebsiella pneumoniae bacteremia? a retrospective case–control study
por: Kang, Chang Kyung, et al.
Publicado: (2013)

Predictive scoring models for persistent gram-negative bacteremia that reduce the need for follow-up blood cultures: a retrospective observational cohort study
por: Jung, Jongtak, et al.
Publicado: (2020)

813. The Reduction of the acquisition rate of carbapenem resistant Acinetobacter baumannii after room privatization in the intensive care unit
por: Jung, Jongtak, et al.
Publicado: (2020)

Human AQP5 Plays a Role in the Progression of Chronic Myelogenous Leukemia (CML)
por: Chae, Young Kwang, et al.
Publicado: (2008)

Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype
por: Kim, Sang-A, et al.
Publicado: (2018)

Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms
por: Kim, Jinyong, et al.
Publicado: (2021)

Concomitant ruxolitinib with cytarabine-based induction chemotherapy in secondary acute myeloid leukemia evolving from myeloproliferative neoplasm
por: Kim, Dong Hyun, et al.
Publicado: (2023)

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM
por: Park, Hyunkyung, et al.
Publicado: (2022)

Effect of Wearing Personal Protective Equipment (PPE) for COVID-19 Treatment on Blood Culture Contamination: Implication for Optimal PPE Strategies
por: Park, Jae Hyeon, et al.
Publicado: (2023)

Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia
por: Shi, Hye Jin, et al.
Publicado: (2020)

Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
por: Park, Hyunkyung, et al.
Publicado: (2019)

Risk Factors for Occurrence and 30-Day Mortality for Carbapenem-Resistant Acinetobacter baumannii Bacteremia in an Intensive Care Unit
por: Kim, Song Yee, et al.
Publicado: (2012)

How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in Korea
por: Park, Do Hyeon, et al.
Publicado: (2022)

Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
por: Lee, Ahreum, et al.
Publicado: (2020)

Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
por: Kim, Dong Hyun, et al.
Publicado: (2022)

Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
por: Seo, Jeongmin, et al.
Publicado: (2021)

O047: The effect of active surveillance culture of carbapenem resistant Acinetobacter baumannii on the occurrence of carbapenem resistant Acinetobacter baumannii bacteremia in a single intensive care unit
por: Kim, G, et al.
Publicado: (2013)

Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae
por: Bang, Ji Hwan, et al.
Publicado: (2013)

Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high‐risk multiple myeloma in Asian patients
por: Byun, Ja Min, et al.
Publicado: (2018)

Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
por: Nam, Chang Hyun, et al.
Publicado: (2021)

Serum Erythropoietin level in anemia of elderly with unclear etiology
por: Seong, Ju Yong, et al.
Publicado: (2023)

Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
por: Kim, Youn Jeong, et al.
Publicado: (2012)

Toll-like receptor 2 downregulation and cytokine dysregulation predict mortality in patients with Staphylococcus aureus bacteremia
por: Kim, Nak-Hyun, et al.
Publicado: (2020)

518. Comparing the Mortality of Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2019)

Strong association between herpes simplex virus-1 and chemotherapy-induced oral mucositis in patients with hematologic malignancies
por: Hong, Junshik, et al.
Publicado: (2020)

Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
por: Byun, Ja Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_32o42cnj7h8u2j30frij55fmhu